Courtesy Getty Images Though a child's HDFN diagnosis is in no way their parent's fault, it is normal to have feelings of guilt after they are diagnosed. When you found out you were pregnant or your ...

Locating blood products for patients with very rare blood groups such as Oh(Bombay) remains difficult and requires careful planning and communication. A recent case report published in Blood Global ...

Courtesy Getty Images Learn more about what you can expect if your child has to stay in a neonatal intensive care unit after birth. Having a child admitted into a neonatal intensive care unit (NICU) ...

Guidelines included information about when and how treatments like IVIG and IUTs should be administered. There are constantly new suggestions on how alloimmunized pregnancies should be managed. In a ...

Lowering harmful maternal antibodies gave fetuses time to grow to safer treatment ages. Double-filtration plasmapheresis, or DFPP, may help some pregnant women with hemolytic disease of the fetus and ...

A second dose of Rhesus immune globulin late in pregnancy may help maintain protection more consistently. Nearly two-thirds of RhD-negative pregnant women who received routine anti-D at 28 weeks lost ...

Research shows a very low risk of developing antibodies tied to HDFN before 12 weeks, which could change routine care. Early evidence now shows that forgoing RhD immune globulin (RhIG) in most ...

The fetus received IVIG, two intrauterine transfusions and four therapeutic plasma exchanges over the course of the pregnancy. A case report and literature review published in the Journal of Perinatal ...

This study found that the main causes of newborn anemia in Africa were linked to the mother’s health and nutrition. About one in three babies in Africa are born with anemia, a condition in which a ...

A pregnant woman receives a fetal ultrasound. (Photo courtesy Johnson & Johnson) Advancements in research and ongoing clinical trials related to HDFN prevention and treatment can change HDFN care for ...

Lisa Shea, director of global patient advocacy and engagement for immunology at Johnson & Johnson, shows a colleague her e-poster at ISUOG 2025 in Cancún, Mexico. (Photo by Larry Luxner) A J&J ...

Standardized protocols may help to address the wide international variation in HDFN treatment and outcomes. A study recently published in Prenatal Diagnosis provides an overview of the evolving ...